 In this study, it was found that Tempol, a well-known antioxidant agent, could reduce the effects of diabetes on the kidneys. Specifically, Tempol reduced the amount of ecaherin, a protein associated with cell adhesion, and increased the amount of alpha-smooth muscle actin, a protein associated with cell migration and proliferation. This suggests that Tempol may be able to prevent the development of chronic kidney disease caused by diabetes. This article was authored by Muhammad Jafari, Fairness Dadras, Hamid Rezaqadimapur, and others.